PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in Pharma

Sep 22

Phil, a leader in patient access solutions for the life sciences industry, today announced the launch of PHIL Direct, its Direct-to-Patient (DTP) 2.0 platform, designed to help pharmaceutical brands meet evolving patient expectations while navigating affordability, compliance, and policy pressures.

Megan Prock McGrath

PHIL Launches Direct-to-Patient 2.0 Platform to Transform Access, Affordability, and Adherence in Pharma

Longevity Health Achieves Top Ratings in CMS Star Quality Measures: A Testament to Excellence in Member Care

89bio, Inc. Announces Agreement to be Acquired by Roche